Effect of Systemic Corticosteroid Therapy on the Efficacy and Safety of Nivolumab in the Treatment of Non-Small-Cell Lung Cancer

INTRODUCTION: Corticosteroids are used to treat immune-related adverse events (irAEs) associated with nivolumab. However, patients with non-small-cell lung cancer who are administered corticosteroids before the initiation of nivolumab treatment are commonly excluded from clinical trials. The appropr...

Descripción completa

Detalles Bibliográficos
Autores principales: Umehara, Kengo, Yama, Kaori, Goto, Keisuke, Wakamoto, Azusa, Hatsuyama, Tae, Honjo, Osamu, Saikai, Toyohiro, Fujita, Akihisa, Sato, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204518/
https://www.ncbi.nlm.nih.gov/pubmed/33733906
http://dx.doi.org/10.1177/1073274820985790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204518/
https://www.ncbi.nlm.nih.gov/pubmed/33733906
http://dx.doi.org/10.1177/1073274820985790

Ejemplares similares